Head-to-Head Startup Ranking & Discovery
AActipulse Neuroscience logo

Actipulse Neuroscience

Health · LatAm · Early-stage
actipulseneuroscience.com
Mental Health TechNeurotechnologyMedical Devices

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.

Founded
2022
Headquarters
Cambridge, MA, USA; Mexico City, CDMX, Mexico
Team size
11–50
Stage
Early-stage
📊 Coliseo ratings
🏆 Overall 1489 Elo
1493
💰 Conviction
Provisional
1483
🔥 Momentum
Provisional
1490
🧲 Talent
Provisional
Total matchups0
⚔️ Vote on today's matchups →

Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →